Sandro Barni


Ontology type: schema:Person     


Person Info

NAME

Sandro

SURNAME

Barni

Publications in SciGraph latest 50 shown

  • 2022-03-30 A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial in GASTRIC CANCER
  • 2021-11-24 Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study in BREAST CANCER RESEARCH AND TREATMENT
  • 2020-01-30 Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study in ADVANCES IN THERAPY
  • 2019-01-18 Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-11-27 Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis in GASTRIC CANCER
  • 2018-10-13 One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-08-20 Patient performance status and cancer immunotherapy efficacy: a meta-analysis in MEDICAL ONCOLOGY
  • 2017-10-15 Molecules, Drugs, and First-Line Therapies: A Guide for the Cardiologist in MANUAL OF CARDIO-ONCOLOGY
  • 2017-07-31 Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-06-26 Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies in MEDICAL ONCOLOGY
  • 2017-03-31 SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab in MEDICAL ONCOLOGY
  • 2017-03-18 Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review in MEDICAL ONCOLOGY
  • 2017-03-15 Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies in ANNALS OF SURGICAL ONCOLOGY
  • 2016-10-21 Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-07-04 TAS-102, the first “cardio-gentle” fluoropyrimidine in the colorectal cancer landscape? in BMC CANCER
  • 2015-12-22 Natural History of Non-Small-Cell Lung Cancer with Bone Metastases in SCIENTIFIC REPORTS
  • 2015-10-05 Signet-ring cell carcinoma of the rectum and synchronous renal cell carcinoma in a young man in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2015-09-04 Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-05-21 Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis in JOURNAL OF GASTROINTESTINAL CANCER
  • 2015-04-28 Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-02-05 Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
  • 2015-01-09 Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patients in MEDICAL ONCOLOGY
  • 2014-11-30 A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2014-11-05 Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients in SCIENTIFIC REPORTS
  • 2014-02-21 The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-12-05 A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice in MEDICAL ONCOLOGY
  • 2013-11-23 Surrogate endpoints in metastatic breast cancer treated with targeted therapies: an analysis of the first-line phase III trials in MEDICAL ONCOLOGY
  • 2013-11-01 Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-07-17 Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-07-05 KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials in MEDICAL ONCOLOGY
  • 2013-06-28 Non-cancer-related mortality after cisplatin-based adjuvant chemotherapy for non-small cell lung cancer: a study-level meta-analysis of 16 randomized trials in MEDICAL ONCOLOGY
  • 2013-02-12 FOLFIRI + bevacizumab as second-line therapy for metastatic colorectal cancer pretreated with oxaliplatin: a pooled analysis of published trials in MEDICAL ONCOLOGY
  • 2013-01-16 The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials in TARGETED ONCOLOGY
  • 2012-11-30 Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer in TARGETED ONCOLOGY
  • 2012-08-08 Malignant Ascites: Diagnosis and Treatment in MALIGNANT EFFUSIONS
  • 2012-07-28 Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression in MEDICAL ONCOLOGY
  • 2012-06-12 Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-05-11 FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-05-01 A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score in INTERNAL AND EMERGENCY MEDICINE
  • 2012-03-14 Role of HER2-neu as a prognostic factor for survival and relapse in pT1a–bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis in MEDICAL ONCOLOGY
  • 2012-02-23 Resectability and outcome with anti-EGFR agents in patients with KRAS wild-type colorectal liver-limited metastases: a meta-analysis in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2011-10-20 Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2011-10-05 Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2011-04-24 5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials in MEDICAL ONCOLOGY
  • 2011-03-13 Meta-analysis of concomitant compared to sequential adjuvant trastuzumab in breast cancer: the sooner the better in MEDICAL ONCOLOGY
  • 2011-03-03 A Rare Case of Metastatic Pancreatic Hepatoid Carcinoma Treated with Sorafenib in JOURNAL OF GASTROINTESTINAL CANCER
  • 2011-02-11 A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer in BREAST CANCER
  • 2011-02-01 Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysis in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2010-12-14 Bevacizumab in advanced breast cancer: an opportunity as second-line therapy? in MEDICAL ONCOLOGY
  • 2010-10-12 Progression of intramedullary metastasis during perioperative cessation of sunitinib in NATURE REVIEWS UROLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.460094.f", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5596.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6292.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413179.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7010.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410345.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8142.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416357.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414818.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411492.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4527.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413174.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418898.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.459640.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415093.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7143.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413937.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7763.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417511.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.509633.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414126.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.22937.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411088.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9657.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415090.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417520.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413503.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417944.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.469662.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417011.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.11450.31", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417270.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411482.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4708.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415025.7", 
            "type": "Organization"
          }
        ], 
        "familyName": "Barni", 
        "givenName": "Sandro", 
        "id": "sg:person.0645550356.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645550356.01"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-09-02T16:34", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/person/person_715.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0645550356.01'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0645550356.01'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0645550356.01'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0645550356.01'


     

    This table displays all metadata directly associated to this object as RDF triples.

    86 TRIPLES      10 PREDICATES      46 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0645550356.01 schema:affiliation N7a0ce657c0334275a826ff4b84abd6da
    2 grid-institutes:grid.11450.31
    3 grid-institutes:grid.22937.3d
    4 grid-institutes:grid.410345.7
    5 grid-institutes:grid.411088.4
    6 grid-institutes:grid.411482.a
    7 grid-institutes:grid.411492.b
    8 grid-institutes:grid.413174.4
    9 grid-institutes:grid.413179.9
    10 grid-institutes:grid.413503.0
    11 grid-institutes:grid.413937.b
    12 grid-institutes:grid.414126.4
    13 grid-institutes:grid.414818.0
    14 grid-institutes:grid.415025.7
    15 grid-institutes:grid.415090.9
    16 grid-institutes:grid.415093.a
    17 grid-institutes:grid.416357.2
    18 grid-institutes:grid.417011.2
    19 grid-institutes:grid.417270.7
    20 grid-institutes:grid.417511.7
    21 grid-institutes:grid.417520.5
    22 grid-institutes:grid.417893.0
    23 grid-institutes:grid.417944.b
    24 grid-institutes:grid.418898.4
    25 grid-institutes:grid.4527.4
    26 grid-institutes:grid.459640.a
    27 grid-institutes:grid.469662.9
    28 grid-institutes:grid.4708.b
    29 grid-institutes:grid.509633.a
    30 grid-institutes:grid.5596.f
    31 grid-institutes:grid.6292.f
    32 grid-institutes:grid.7010.6
    33 grid-institutes:grid.7143.1
    34 grid-institutes:grid.7763.5
    35 grid-institutes:grid.8142.f
    36 grid-institutes:grid.9657.d
    37 schema:familyName Barni
    38 schema:givenName Sandro
    39 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645550356.01
    40 schema:sdDatePublished 2022-09-02T16:34
    41 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    42 schema:sdPublisher N4e894d54a4bc459b8e8cc1a358c9d7ef
    43 sgo:license sg:explorer/license/
    44 sgo:sdDataset persons
    45 rdf:type schema:Person
    46 N4e894d54a4bc459b8e8cc1a358c9d7ef schema:name Springer Nature - SN SciGraph project
    47 rdf:type schema:Organization
    48 N7a0ce657c0334275a826ff4b84abd6da schema:affiliation grid-institutes:grid.460094.f
    49 sgo:isCurrent true
    50 rdf:type schema:OrganizationRole
    51 grid-institutes:grid.11450.31 schema:Organization
    52 grid-institutes:grid.22937.3d schema:Organization
    53 grid-institutes:grid.410345.7 schema:Organization
    54 grid-institutes:grid.411088.4 schema:Organization
    55 grid-institutes:grid.411482.a schema:Organization
    56 grid-institutes:grid.411492.b schema:Organization
    57 grid-institutes:grid.413174.4 schema:Organization
    58 grid-institutes:grid.413179.9 schema:Organization
    59 grid-institutes:grid.413503.0 schema:Organization
    60 grid-institutes:grid.413937.b schema:Organization
    61 grid-institutes:grid.414126.4 schema:Organization
    62 grid-institutes:grid.414818.0 schema:Organization
    63 grid-institutes:grid.415025.7 schema:Organization
    64 grid-institutes:grid.415090.9 schema:Organization
    65 grid-institutes:grid.415093.a schema:Organization
    66 grid-institutes:grid.416357.2 schema:Organization
    67 grid-institutes:grid.417011.2 schema:Organization
    68 grid-institutes:grid.417270.7 schema:Organization
    69 grid-institutes:grid.417511.7 schema:Organization
    70 grid-institutes:grid.417520.5 schema:Organization
    71 grid-institutes:grid.417893.0 schema:Organization
    72 grid-institutes:grid.417944.b schema:Organization
    73 grid-institutes:grid.418898.4 schema:Organization
    74 grid-institutes:grid.4527.4 schema:Organization
    75 grid-institutes:grid.459640.a schema:Organization
    76 grid-institutes:grid.460094.f schema:Organization
    77 grid-institutes:grid.469662.9 schema:Organization
    78 grid-institutes:grid.4708.b schema:Organization
    79 grid-institutes:grid.509633.a schema:Organization
    80 grid-institutes:grid.5596.f schema:Organization
    81 grid-institutes:grid.6292.f schema:Organization
    82 grid-institutes:grid.7010.6 schema:Organization
    83 grid-institutes:grid.7143.1 schema:Organization
    84 grid-institutes:grid.7763.5 schema:Organization
    85 grid-institutes:grid.8142.f schema:Organization
    86 grid-institutes:grid.9657.d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...